Latest News and Press Releases
Want to stay updated on the latest news?
-
København, 2015-12-15 09:00 CET (GLOBE NEWSWIRE) -- Finanskalender 2016 for ALK (ALKB:DC / OMX: ALK B / AKABY /...
-
Copenhagen, 2015-12-15 09:00 CET (GLOBE NEWSWIRE) -- 2016 financial calendar for ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): Silent...
-
Copenhagen, 2015-12-09 11:50 CET (GLOBE NEWSWIRE) -- Three months ago, ALK's new sublingual allergy immunotherapy tablet for the treatment of allergic rhinitis and allergic asthma was...
-
Copenhagen, 2015-11-26 02:00 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that the sublingual allergy immunotherapy product MITICURE™ now will be...
-
København, 2015-11-26 02:00 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) meddelte i dag, at tabletvaccinen MITICURE™ nu bliver tilgængelig på recept i Japan til voksne...
-
Copenhagen, 2015-11-12 08:00 CET (GLOBE NEWSWIRE) -- Performance for the period (unaudited) (Comparative figures for 2014 are shown in brackets / revenue growth is measured in local...
-
København, 2015-11-12 08:00 CET (GLOBE NEWSWIRE) -- Bemærk venligst, at halvårsrapporten kun foreligger på engelsk. Performance for the period (unaudited) (Comparative figures for 2014...
-
Copenhagen, 2015-11-06 12:15 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that the Company will present at the Jefferies Autumn 2015 Global Healthcare...
-
Copenhagen, 2015-11-04 17:04 CET (GLOBE NEWSWIRE) -- On Thursday, 12 November 2015, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its interim report for the nine months ended 30...
-
København, 2015-11-04 17:04 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) offentliggør torsdag den 12. november 2015 delårsrapport for 9 måneder (Q3) 2015. ALK...